Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

Impact Report IMPACT REPORT 2022 – 2023 2022 – 2023 __________   My Story My Story Karen Noel After 25 years as a teacher, many of them working with special […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

WILLS AND ESTATES Help Canadians Affected by Osteoporosis by Leaving a Gift in Your Will When you leave a gift to Osteoporosis Canada in your Will, you can feel confident […]

IMPACT REPORT 2020 – 2021 __________   PATIENT STORYJOYCE CRAWFORD Joyce’s father had osteoporosis and even though her grandmother wasn’t formally diagnosed, she had signs of the disease including her […]

There is no excerpt because this is a protected post.

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]